Form 8-K - Current report:
SEC Accession No. 0001213900-21-052106
Filing Date
2021-10-08
Accepted
2021-10-08 17:16:17
Documents
13
Period of Report
2021-10-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea148612-8k_aditxtinc.htm   iXBRL 8-K 40858
2 PRESS RELEASE, DATED OCTOBER 5, 2021 ea148612ex99-1_aditxtinc.htm EX-99.1 21755
  Complete submission text file 0001213900-21-052106.txt   248745

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adtx-20211004.xsd EX-101.SCH 3028
4 XBRL LABEL FILE adtx-20211004_lab.xml EX-101.LAB 34231
5 XBRL PRESENTATION FILE adtx-20211004_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT ea148612-8k_aditxtinc_htm.xml XML 3695
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 211316051
SIC: 2834 Pharmaceutical Preparations